[Influence of COVID-19 on the occurrence and treatment of hemolytic diseases].

Wang, Z; Zhao, Y P

Wang, Z; Zhao, Y P.

Wang Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Zhao YP; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Zhonghua Xue Ye Xue Za Zhi ; 41(10): 878-880, 2020 10 14.

Article in Chinese | MEDLINE | ID: covidwho-945977

Subject(s)

Coronavirus Infections/complications; Hematologic Diseases/complications; Hematologic Diseases/therapy; Pneumonia, Viral/complications; Betacoronavirus; COVID-19; Humans; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Hematologic Diseases Topics: Long Covid Limits: Humans Language: Chinese Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2020 Document Type: Article Affiliation country: Cma.j.issn.0253-2727.2020.10.021

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google